Rectal cancer originates in the rectum (the last inches of the intestinal tract) and is commonly marked by symptoms such as unintended weight loss, extreme fatigue, rectal bleeding, and variations in appetite and frequency. It begins in small clumps known as polyps, most commonly benign, that may develop into cancer overtime. Although its cause is unknown, smoking, inflammatory bowel disease, an inactive lifestyle, a high-fat and low-fiber diet, as well as old age are common risk factors for rectal cancer. Treatments for rectal cancer include surgery, chemotherapy, and radiation therapy. Stage I rectal cancer can be divided into two groups: type 1 and type 2. In type 1, the tumor invades the submucosa, yet has not relocated to nearby lymph nodes or organs. In type 2, the tumor has grown into the muscularis propria, but has not spread to distant or nearby lymph nodes or organs.
Stage I Rectal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage I Rectal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 881 products for the study of Stage I Rectal Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.